SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-078355
Filing Date
2007-10-31
Accepted
2007-10-31 12:18:01
Documents
5
Period of Report
2007-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-27705_18k.htm 8-K 29700
2 EX-3.2 a07-27705_1ex3d2.htm EX-3.2 222154
3 EX-99.1 a07-27705_1ex99d1.htm EX-99.1 9292
4 GRAPHIC g277051mmi001.jpg GRAPHIC 1735
5 GRAPHIC g277051mmi002.jpg GRAPHIC 4318
  Complete submission text file 0001104659-07-078355.txt   271487
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 071201802
SIC: 2834 Pharmaceutical Preparations